Answers are grounded in this paper and cite their sources.
Introduction: Thrombotic microangiopathies are a group of diseases characterized by disseminated intravascular thrombosis, thrombocytopenia and ischemic organ damage. This group includes thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome. One of the causes of thrombotic microangiopathy, although rare, can also be malignant diseases, primarily cancers of the stomach, prostate, breast and lungs. Case report: We present a patient with thrombotic microangiopathy and disseminated malignant disease of unclear etiology. Conclusion: This clinical entity is called carcinoma-associated thrombotic microangiopathy and was first described in 1970. However, only a few dozen cases have been described to date. Considering the high mortality, it should be considered in patients with malignant disease, microangiopathic hemolytic anemia, and thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Todorović et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: